INmune Bio Inc. (INMB) Financials
INMB Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 57.0 million | 18.9 million |
2023-09-30 | 62.7 million | 18.0 million |
2023-06-30 | 69.7 million | 19.1 million |
2023-03-31 | 74.0 million | 18.7 million |
INMB Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -3.4 million | 1.9 million |
2023-09-30 | -4.3 million | 1.9 million |
2023-06-30 | -3.2 million | 1.9 million |
2023-03-31 | -1.1 million | 1.7 million |
INMB Net Income
No data available :(
INMB Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 35.8 million | - | 516000 |
2023-09-30 | 41.8 million | - | 536000 |
2023-06-30 | 47.8 million | 4.8 million | 564000 |
2023-03-31 | 51.0 million | 7.3 million | 604000 |
INMB Shares Outstanding
INMB Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 6.0 million | 2.4 million | - |
2023-09-30 | - | 6.0 million | 2.6 million | - |
2023-06-30 | - | 4.1 million | 2.3 million | - |
2023-03-31 | - | 4.1 million | 2.3 million | - |
INMB Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | 28000 | - |
2023-09-30 | 43000 | - |
2023-06-30 | 46000 | - |
2023-03-31 | 38000 | - |
INMB
Price: $11.57
52 week price:
Earnings Per Share: -1.67 USD
P/E Ratio: -8.37
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 49961
Market Capitalization: 219.9 million